These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23289618)

  • 1. Targeted drug delivery to macrophages.
    Jain NK; Mishra V; Mehra NK
    Expert Opin Drug Deliv; 2013 Mar; 10(3):353-67. PubMed ID: 23289618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro- and nanocarrier-mediated lung targeting.
    Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
    Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated drug delivery.
    Batrakova EV; Gendelman HE; Kabanov AV
    Expert Opin Drug Deliv; 2011 Apr; 8(4):415-33. PubMed ID: 21348773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
    Lee WH; Loo CY; Traini D; Young PM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
    Khan T; Mayuresh Patkar M; Momin M; Omri A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Developments in the Area of Click-Crosslinked Nanocarriers for Drug Delivery.
    Dai Y; Chen X; Zhang X
    Macromol Rapid Commun; 2019 Feb; 40(3):e1800541. PubMed ID: 30417477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent development of targeted drug delivery system].
    Zhou PJ; Deng SQ; Gong QF
    Yao Xue Xue Bao; 2010 Mar; 45(3):300-6. PubMed ID: 21351504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to macrophages: Challenges and opportunities.
    Pei Y; Yeo Y
    J Control Release; 2016 Oct; 240():202-211. PubMed ID: 26686082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.
    Mbah CC; Builders PF; Attama AA
    Expert Opin Drug Deliv; 2014 Jan; 11(1):45-59. PubMed ID: 24294974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drugs and nanomedicine: present and future.
    Debbage P
    Curr Pharm Des; 2009; 15(2):153-72. PubMed ID: 19149610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery.
    Zhang L; Sang Y; Feng J; Li Z; Zhao A
    J Drug Target; 2016 Aug; 24(7):579-89. PubMed ID: 26766303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
    Ahsan F; Rivas IP; Khan MA; Torres Suarez AI
    J Control Release; 2002 Feb; 79(1-3):29-40. PubMed ID: 11853916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical drug delivery systems: a patent review.
    Singh Malik D; Mital N; Kaur G
    Expert Opin Ther Pat; 2016; 26(2):213-28. PubMed ID: 26651499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox biology of Leishmania and macrophage targeted nanoparticles for therapy.
    Sarwar HS; Akhtar S; Sohail MF; Naveed Z; Rafay M; Nadhman A; Yasinzai M; Shahnaz G
    Nanomedicine (Lond); 2017 Jul; 12(14):1713-1725. PubMed ID: 28635366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.
    Soliman GM; Sharma A; Maysinger D; Kakkar A
    Chem Commun (Camb); 2011 Sep; 47(34):9572-87. PubMed ID: 21655634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-Targeted Therapeutics for Metabolic Disease.
    Peterson KR; Cottam MA; Kennedy AJ; Hasty AH
    Trends Pharmacol Sci; 2018 Jun; 39(6):536-546. PubMed ID: 29628274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.